ProShare Advisors LLC reduces its stake in
The Clorox Company while
Benjamin F. Edwards & Company Inc increases its position. Clorox continues with its payment of the regular
quarterly dividend. Despite daily variations, Clorox outperforms competitors. Recently Clorox completed the announced divestiture of its
Better Health VMS Business. Hsbc Holdings PLC buys more shares of Clorox which is still a favourite among institutional investors with 81% ownership. Clorox presents at the Barclays Global Consumer Staples Conference and continues with its efforts of product donations. Several management transactions happen as the EVP sells about $286,846.16 in stock. Clorox decommissions its operations in
Argentina, Uruguay, and Paraguay and the company's stock remains a point of interest despite the 31% undervaluation. Better Health VMS Business sale aids CLX stock. Clorox's earnings continue to rise amidst challenges and current earnings might be conservative. Clorox stock reaches a new high of
$168.82. Lowered stakes, sales growth, margin expansion and strong forward guidance underscores robust Q4 financial results. However, shares cross the 3% yield mark due to heightened competition. Despite a market dip since the last earnings report, Clorox shines as a dividend aristocrat and stands out in household products earnings, indicating defensive play potential.
Clorox Company CLX News Analytics from Thu, 02 Nov 2023 07:00:00 GMT to Sun, 22 Sep 2024 15:29:24 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor -5
